UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 199

Sortiert nach

Epigenetics of lung cancer

Translational research : the journal of laboratory and clinical medicine, 2015-01, Vol.165 (1), p.74-90

2015

Volltextzugriff (PDF)

Oncolytic virus therapy for cancer: the first wave of translational clinical trials

Translational research : the journal of laboratory and clinical medicine, 2013-04, Vol.161 (4), p.355-364

2013

Volltextzugriff (PDF)

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2016-04, Vol.34 (11), p.1223-1230

2016

Volltextzugriff (PDF)

Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide

PloS one, 2013-11, Vol.8 (11), p.e81669

2013

Volltextzugriff (PDF)

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-10, Vol.36 (30), p.2995-3006

2018

Volltextzugriff (PDF)

Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer

The Annals of thoracic surgery, 2007-06, Vol.83 (6), p.1965-1970

2007

Volltextzugriff (PDF)

SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer

International journal of molecular sciences, 2023-08, Vol.24 (15), p.12500

2023

Volltextzugriff (PDF)

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3439-3446

2015

Volltextzugriff (PDF)

Oncolytic Viral Therapy for Mesothelioma

Frontiers in oncology, 2017-08, Vol.7, p.179-179

2017

Volltextzugriff (PDF)

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Oncotarget, 2015-10, Vol.6 (32), p.33165-33177

2015

Volltextzugriff (PDF)

Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation

European journal of pharmaceutical sciences, 2024-02, Vol.193, p.106686-106686, Article 106686

2024

Volltextzugriff (PDF)

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Cancer gene therapy, 2019-11, Vol.26 (11-12), p.411-418

2019

Volltextzugriff (PDF)

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3120-3125

2011

Volltextzugriff (PDF)

miR-1 Induces Growth Arrest and Apoptosis in Malignant Mesothelioma

Chest, 2013-11, Vol.144 (5), p.1632-1643

2013

Volltextzugriff (PDF)

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non―Small Cell Lung Cancer

Anesthesia and analgesia, 2011-12, Vol.113 (6), p.1353-1364

2011

Volltextzugriff (PDF)

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2173-2181

2013

Volltextzugriff (PDF)

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1 , ARF , and p53

International journal of molecular sciences, 2020-10, Vol.21 (21), p.7971

2020

Volltextzugriff (PDF)

Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade

Cancer Immunology, Immunotherapy, 2023-05, Vol.72 (5), p.1225-1232

2023

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2063-2069

2012

Volltextzugriff (PDF)

Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer

Translational oncology, 2020-07, Vol.13 (7), p.100782-100782, Article 100782

2020

Volltextzugriff (PDF)

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

Frontiers in immunology, 2023-02, Vol.14, p.1060905-1060905

2023

Volltextzugriff (PDF)

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Journal of clinical oncology, 2008-02, Vol.26 (6), p.848-855

2008

Volltextzugriff (PDF)

Targeting eukaryotic protein translation in mesothelioma

Translational lung cancer research, 2017-06, Vol.6 (3), p.343-349

Kratzke, Robert A.

2017

Volltextzugriff (PDF)

Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B

Clinical cancer research, 2005-03, Vol.11 (6), p.2300-2304

2005

Volltextzugriff (PDF)

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

Investigational new drugs, 2018-04, Vol.36 (2), p.217-229

2018

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

Englisch
(199)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Life Sciences & Biomedicine
(121)
Humans
(114)
Oncology
(81)
Biological And Medical Sciences
(51)
Medical Sciences
(50)
Male
(48)
Female
(44)
Middle Aged
(41)
Respiratory System
(41)
Aged
(39)
Lung Neoplasms - Pathology
(39)
Pneumology
(31)
Tumors
(29)
Adult
(28)
Tumors Of The Respiratory System And Mediastinum
(28)
Lung Cancer
(27)
Prognosis
(26)
Carcinoma, Non-Small-Cell Lung - Pathology
(25)
Aged, 80 And Over
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epigenetics of lung cancer

Oncolytic virus therapy for cancer: the first wave of translational clinical trials

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer

SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Oncolytic Viral Therapy for Mesothelioma

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

miR-1 Induces Growth Arrest and Apoptosis in Malignant Mesothelioma

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non―Small Cell Lung Cancer

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1 , ARF , and p53

Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Targeting eukaryotic protein translation in mesothelioma

Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

Suchergebnisse filtern